These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10225567)
1. In-vitro susceptibility of 1982 respiratory tract pathogens and 1921 urinary tract pathogens against 19 antimicrobial agents: a Canadian multicentre study. Canadian Antimicrobial Study Group. Blondeau JM; Yaschuk Y; Suter M; Vaughan D J Antimicrob Chemother; 1999 Mar; 43 Suppl A():3-23. PubMed ID: 10225567 [TBL] [Abstract][Full Text] [Related]
2. Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin. Blondeau JM; Suter ME; Borsos S; Misfeldt C Int J Antimicrob Agents; 1998 Nov; 10(4):297-302. PubMed ID: 9916904 [TBL] [Abstract][Full Text] [Related]
3. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group. Jones RN; Salazar JC; Pfaller MA; Doern GV Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa. Greenberg RN; Bollinger MR; Alivisatos MR Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of 19 antimicrobial agents against 3513 nosocomial pathogens collected from 48 Canadian medical centres. The Canadian Antimicrobial Study Group. Blondeau JM; Vaughan D Int J Antimicrob Agents; 2000 Aug; 15(3):213-9. PubMed ID: 10926444 [TBL] [Abstract][Full Text] [Related]
6. Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results. Jones RN; Sutton LD; Cantrell HF; Lankford RB Diagn Microbiol Infect Dis; 1994 Nov; 20(3):143-9. PubMed ID: 7874881 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States, I. Study on the threat of emerging resistances: real or perceived? Fluoroquinolone Resistance Surveillance Group. Jones RN; Kehrberg EN; Erwin ME; Anderson SC Diagn Microbiol Infect Dis; 1994 Aug; 19(4):203-15. PubMed ID: 7851083 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period 1997-1999. Fontana R; Lo Cascio G; Ligozzi M; Friscia O; Oldoni T; Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):854-63. PubMed ID: 11837636 [TBL] [Abstract][Full Text] [Related]
9. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin. Digranes A; Dibb WL; Benonisen E; Salveson A Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281 [TBL] [Abstract][Full Text] [Related]
10. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia]. Monteil H; Jehl F Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818 [TBL] [Abstract][Full Text] [Related]
11. Comparative activity of newer antibiotics against gram-negative bacilli. Knapp CC; Washington JA Cleve Clin J Med; 1989; 56(2):161-6. PubMed ID: 2731335 [TBL] [Abstract][Full Text] [Related]
12. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China]. Chen MJ; Wang H; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912 [TBL] [Abstract][Full Text] [Related]
13. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa. Heym B; Lacroix O; Péan Y; Gertner J; Nicolas MH; Jarlier V J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691 [TBL] [Abstract][Full Text] [Related]
14. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections. Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524 [TBL] [Abstract][Full Text] [Related]
16. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China]. Wang H; Chen MJ; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914 [TBL] [Abstract][Full Text] [Related]
17. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus. Campos P; Vera A; Martin-Luengo F Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358 [No Abstract] [Full Text] [Related]
18. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa. Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715 [TBL] [Abstract][Full Text] [Related]
19. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents. Henry D; Skidmore AG; Ngui-Yen J; Smith A; Smith JA Antimicrob Agents Chemother; 1985 Aug; 28(2):259-64. PubMed ID: 3869433 [TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of the antimicrobial activity for seven broad-spectrum beta-lactams in Turkey using the Etest method. Turkish Antimicrobial Resistance Study Group. Pfaller MA; Korten V; Jones RN; Doern GV Diagn Microbiol Infect Dis; 1999 Sep; 35(1):65-73. PubMed ID: 10529883 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]